Up next

Autoplay

What are the risks for new medication targeting hot flashes during menopause? | NewsNation Live

0 Views • 08/28/25
Share
Side Effects
Side Effects
Subscribers
0

The FDA approved the once-a-day pill from Astellas Pharma to treat moderate-to-severe symptoms, which can include sweating, flushing and chills. Dr. Megan Ranney explains the risk women encounter when they choose to use this drug to help their symptoms of menopause.

#menopause #hotflashes #FDA

Get a fast-paced look at the latest from the border to Main Street to the White House on "NewsNation Live with Marni Hughes." Weekdays starting at 10a/9C.#NewsNationLive

NewsNation is your source for fact-based, unbiased news for all America.

More from NewsNation: https://www.newsnationnow.com/
Get our app: https://trib.al/TBXgYpp
Find us on cable: https://trib.al/YDOpGyG
How to watch on TV or streaming: https://trib.al/Vu0Ikij

Show more
0 Comments sort Sort By

Up next

Autoplay